The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus.
about
Cytoskeletal dependence of insulin granule movement dynamics in INS-1 beta-cells in response to glucoseβ-cell dysfunction: Its critical role in prevention and management of type 2 diabetes.An Islet-Targeted Genome-Wide Association Scan Identifies Novel Genes Implicated in Cytokine-Mediated Islet Stress in Type 2 Diabetes.Stress-induced dissociations between intracellular calcium signaling and insulin secretion in pancreatic isletsLow sensitivity of the metabolic syndrome to identify adolescents with impaired glucose tolerance: an analysis of NHANES 1999-2010.The use of proteomics in identifying differentially expressed serum proteins in humans with type 2 diabetesA thyroid hormone challenge in hypothyroid rats identifies T3 regulated genes in the hypothalamus and in models with altered energy balance and glucose homeostasis.An integrated glucose-insulin model to describe oral glucose tolerance test data in healthy volunteers.Prkar1a in the regulation of insulin secretion.Sitagliptin Improves the Impaired Acute Insulin Response during a Meal Tolerance Test in Japanese Patients with Type 2 Diabetes Mellitus: A Small-Scale Real-World Study.A variation in NOS1AP gene is associated with repaglinide efficacy on insulin resistance in type 2 diabetes of Chinese.Obesity attenuates the contribution of African admixture to the insulin secretory profile in peripubertal children: a longitudinal analysisCyclic AMP sensor EPAC proteins and energy homeostasis.Meal feeding improves oral glucose tolerance in male rats and causes adaptations in postprandial islet hormone secretion that are independent of plasma incretins or glycemia.Targeted inactivation of kinesin-1 in pancreatic β-cells in vivo leads to insulin secretory deficiency.Lixisenatide resensitizes the insulin-secretory response to intravenous glucose challenge in people with type 2 diabetes--a study in both people with type 2 diabetes and healthy subjects.Snapin mediates incretin action and augments glucose-dependent insulin secretionAdiposity and β-cell function: relationships differ with ethnicity and ageDiabetes mellitus and its chronic complications.The proinsulin/insulin (PI/I) ratio is reduced by postprandial targeting therapy in type 2 diabetes mellitus: a small-scale clinical study.Dietary macronutrient composition affects β cell responsiveness but not insulin sensitivity.The estimation of first-phase insulin secretion by using components of the metabolic syndrome in a chinese population.L-cysteine reversibly inhibits glucose-induced biphasic insulin secretion and ATP production by inactivating PKM2Enhanced glycemic control with combination therapy for type 2 diabetes in primary care.Loss of huntingtin-associated protein 1 impairs insulin secretion from pancreatic β-cells.PKA Enhances the Acute Insulin Response Leading to the Restoration of Glucose Control.Importance of Beta Cell Function for the Treatment of Type 2 DiabetesCoconut-derived D-xylose affects postprandial glucose and insulin responses in healthy individuals.What does postprandial hyperglycaemia mean?IGF2BP1, IGF2BP2 and IGF2BP3 genotype, haplotype and genetic model studies in metabolic syndrome traits and diabetes.Sulfonylurea treatment of type 2 diabetes mellitus: focus on glimepiride.First-phase insulin secretion: does it exist in real life? Considerations on shape and function.Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets.Regulation of transforming growth factor beta in diabetic nephropathy: implications for treatment.Faster-acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart.Proteins altered by elevated levels of palmitate or glucose implicated in impaired glucose-stimulated insulin secretion.The glucose transporter 2 undergoes plasma membrane endocytosis and lysosomal degradation in a secretagogue-dependent manner.Insulin granule biogenesis, trafficking and exocytosis.A Spatial Model of Insulin-Granule Dynamics in Pancreatic β-Cells.Early metabolic markers of islet allograft dysfunction.
P2860
Q27342218-DA6BC34A-6022-48A7-907E-3711AC181257Q27692665-23C7A9EF-226C-465D-8CD2-A706E682103CQ30279270-6F4D0B27-2119-40B9-A505-A9F179598A08Q30300205-363CA15C-B6B9-43B0-B33A-11367F10CDA8Q30413659-DCD5F3D9-1633-4749-AF65-EB0F76F9FA1AQ30828348-B96A9D12-5757-4CD6-8F64-1D2EC8F1136CQ30840421-2291AE6E-89E4-406B-91CF-7AAD9F42DE4DQ33516679-2C44688E-4424-427E-BE6A-9F15E4DE13BBQ33664930-4842AAD9-FFAA-46AA-93D8-E3E88918CD6DQ33785132-9D014455-04E2-4A65-9094-5CC17D6C80A6Q33814072-4A980E52-18C9-47B6-98AD-3FFBBB0BFECCQ34122480-F840B322-10D6-4150-ADE3-9F7D0F16B0EEQ34385094-AA785B66-8B93-4050-962F-58AD0F6E5F98Q34439517-DED13CAE-A18D-4C2F-84A3-05CE92A039D8Q34448753-1A60191C-3973-4036-A36F-D5E4BF4E3B0AQ34543003-91C0CCC1-F50E-482D-AAE4-4C7F17F302ADQ34648996-93389829-7AC5-4F87-9B14-CFE4682E8CD6Q34781467-708C77D3-E84A-468B-8A8E-EDFF2F69D00CQ34795600-6AB4FB46-1FD5-4856-B474-276C8F10AEFAQ35038525-883334FE-108C-4887-BC16-71DB20D59EDBQ35080402-144EACB8-47B1-4319-9B39-E6A2DFDF6B1EQ35177930-E506F20D-0B41-41EA-AFCC-B42AEB961975Q35189922-379D857B-CBF7-47F4-A5C3-8728B975701FQ35214435-E793FC7A-C8E4-4D2F-B051-B8F090871EB9Q35350377-8EEF3D68-62B7-490A-90B0-4674F07E7581Q35532241-9CD43B71-5249-471F-BED6-C81EA7FC2050Q35667116-2409FC2D-6C83-4EE3-BBDF-B251BFD75C5EQ35675502-3150FC0A-B1F2-4B05-A072-C4E1F40EB832Q35685742-073339CB-D3F4-475C-8BB3-DFEC95B85668Q35708056-A5A0F4EA-BDA9-4F72-B143-8A168FAB80D1Q35783714-E3947DAC-D130-4916-8E67-CE9E50C40B86Q35861874-023077D0-5EF3-49C2-896B-054D678CAB57Q36499679-80C80FF3-7980-4D27-94DF-3D9492BC0D69Q36785571-48213864-95E5-4E3D-8F21-53DCB0069B27Q37320243-1C3745F0-07BF-4D1A-88E1-AD63ED6E543EQ37320446-8095BD0E-6919-4A2D-872A-047A0BB7371AQ37328804-E2F5F3FB-C355-49EA-ABCE-B621F7A40B22Q37403987-E8CD355F-1548-413B-946E-4C2E7D1F8D65Q41159268-EB8B0CEB-5F9A-4542-8A45-4F16FA554620Q41769630-7FE165B1-51B0-4BFF-9830-2108CD95949A
P2860
The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The importance of first-phase ...... y of type 2 diabetes mellitus.
@ast
The importance of first-phase ...... y of type 2 diabetes mellitus.
@en
The importance of first-phase ...... y of type 2 diabetes mellitus.
@nl
type
label
The importance of first-phase ...... y of type 2 diabetes mellitus.
@ast
The importance of first-phase ...... y of type 2 diabetes mellitus.
@en
The importance of first-phase ...... y of type 2 diabetes mellitus.
@nl
prefLabel
The importance of first-phase ...... y of type 2 diabetes mellitus.
@ast
The importance of first-phase ...... y of type 2 diabetes mellitus.
@en
The importance of first-phase ...... y of type 2 diabetes mellitus.
@nl
P2860
P356
P1476
The importance of first-phase ...... y of type 2 diabetes mellitus.
@en
P2093
P2860
P304
P356
10.1002/DMRR.198
P577
2001-05-01T00:00:00Z